메인콘텐츠 바로가기 메뉴영역 바로가기
하이로닉 로고

하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.

인터내셔널 웹사이트 →

It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.

International Website →
닫기
하이로닉 로고

하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

US 웹사이트 →

It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

US Website →
닫기
하이로닉 로고

하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

EU 웹사이트 →

It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

EU Website →
닫기
NEWS

총 242개의 게시물이 있습니다.

NEWS 목록 : 번호, 제목, 첨부, 작성일, 조회로 구성
Dear Valued Partners and Clients,As someone who has been with HIRONIC from its inception, I am thrilled to continue our legacy of innovation and excellence in the aesthetic medical device industry. Our mission at HIRONIC has always been to enrich society and our customers’ welfare through innovative medical devices. We are dedicated to enhancing the quality of life for our users and expanding the possibilities within skin beauty technology.Looking ahead, we are committed to becoming the No.1 company in the global aesthetic medical device industry by 2030. We have set a clear vision to achieve the highest level of customer satisfaction and to elevate the quality of our services and products to the highest standards. These opportunities and challenges fill me with great anticipation.We will maintain the trust and confidence you have placed in us, and we are devoted to providing solutions that meet the evolving needs of our global customers. We are grateful for your ongoing partnership and support. Together, we will set new industry standards, ensuring that our products not only meet but exceed your expectations. We sincerely welcome your continuous advice and interest.Best regards, Jinu LeeCEO, HIRONIC 
2024-08-14
We're excited to share a behind-the-scenes look at the preparations for our upcoming webinar and clinical sessions. Did you know that our New Doublo2.0 is not only revolutionary for facial lifting but also highly effective for body lifting and contouring? From basic principles to advanced techniques, our upcoming sessions will cover everything you need to know about utilizing New Doublo2.0's FL and SD for face and body lifting, as well as RM for rejuvenation and pigment treatment.Don’t miss out on these insightful sessions. Stay tuned and be ready to learn with us!   
2024-08-14
We are announcing an exclusive distribution agreement with Ukrainian medical device distributor Under this agreement, Hironic will supply five types of products: 'Doublo Gold', 'Silkro', 'New Doublo 2.0', 'Picohi', and 'Ultra Vera', through the fourth quarter of 2026. 
2024-08-14
 Hironic announced that it received import approval from the Central Drugs Standard Control Organization (CDSCO) of India for three of its medical devices: Doublo Gold ™, Ultra Vera ™, and Micool S™. A company spokesperson stated, "This approval opens the door for Hironic's medical devices to make a significant entry into the Indian market. Particularly, our HIFU product line had already been in demand by various buyers in India even before this approval. "In other developments, Hironic has reported an increase in exports in the first quarter of this year compared to the same period last year, indicating a significant expansion in the global market. From the second quarter, the company anticipates further expansion of its export volumes as its key products receive approvals in markets including Europe, Brazil, Peru, and Vietnam. 
2024-08-14
Hironic has announced the commencement of exports to the Brazilian market following a strategic distribution agreement signed in June. The first order includes Hironic's flagship products: NEW DOUBLO 2.0™, SILKRO ™ (Total RF Solution), and PLASONIC ™. We express that this shipment marks the first entry of Hironic products into the Brazilian market following the acquisition of ANVISA certification, underscoring its significance. Considering the potential of the Brazilian aesthetic medical device market, the stature of Hironic products in the South American market, and their competitive quality and pricing, Hironic anticipates a sustained increase in exports to the South American markets. 
2024-08-14
 Hironic has announced the successful registration of its ND:Yag laser surgery device 'PICOHI™' with the Medical Device Authority (MDA) of Malaysia. Malaysia's medical device regulations require registration for the import, export, and market launch of medical devices. This registration opens the path for the export of 'PICOHI™' to Malaysia, according to a company spokesperson. Previously, 'PICOHI™' had already obtained the 510(k) clearance from the U.S. FDA (Food and Drug Administration) in 2021.
2024-07-25
The 15th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!    
2024-07-04
NEW ON-DEMAND LECTURE VIDEOS NOW AVAILABLE! - Comprehensive insights from past HIRONIC symposiums- Expert lectures from key doctors around the world- Practical tips and techniques for enhancing treatment efficacyThe lectures are equipped with English subtitles for our global partners. 
2024-07-03
We are delighted to announce that HIRONIC has been selected as a '2024 Global IP Star Company' under the IP-Based Overseas Expansion Support Program.Our ongoing focus on research and development has already resulted in a robust portfolio of about 407 intellectual property rights, encompassing patents, utility models, trademarks, and designs, both domestically and internationally as of the end of March.We are building customer satisfaction and trust with products differentiated through R&D. We continue to develop intellectual property and focus on securing patents," a HIRONIC representative noted. With the support of this program, we are dedicated to further enhancing our global market competitiveness and striving to become a leading small yet robust enterprise.Thank you for your continued support and partnership as we embark on this exciting new chapter in our journey towards global expansion and innovation.   
2024-07-03
Dear Partners,We are sharing a significant update from HIRONIC that promises to enhance our global competitiveness and innovation in medical aesthetic technology. Our multifunctional RF aesthetic device, Silkro™, has received FDA 510(k) clearance for an exciting New addition: the Plasma (PS) handpiece.Silkro™, which utilizes micro-needle technology to deliver high-frequency (RF) currents for tissue coagulation and pain relief, previously featured four types of handpieces: RM (RF Micro Needle), RN (RF Needle), RC (RF Circle), and RV (RF Vaginal). When combined with RF treatment, plasma enhances therapeutic outcomes by intensifying energy delivery and improving precision, which facilitates more effective tissue coagulation and healing. It also brings sterilizing and disinfecting benefits by generating reactive species that effectively destroy bacteria and viruses, reducing the risk of infection and promoting a safer treatment environment. This synergy results in more efficient treatments with potentially shorter recovery times and improved results. This latest FDA approval underlines HIRONIC’s relentless pursuit of excellence and innovation. It reaffirms our technological prowess and the safety of our products on an international stage, strengthening our position in the global market. We look forward to the opportunities this expansion will bring and are excited to see the positive impact it will have on your markets. Thank you for your continued support as we push the boundaries of medical aesthetic technology together.
2024-07-03
Dear our valued partners.We are thrilled to announce the 18th anniversary of HIRONIC. Over the past 18 years, we've grown into a global leader in the beauty aesthetic medical device industry, committed to enhancing beauty and skin health worldwide.Our Journey: From our first product launch to our latest innovation, our journey has been fueled by a commitment to quality and a passion for progress. Our products have reached over 60+ countries.Looking Forward: As we celebrate this milestone, we are also looking forward to unveiling new technologies and further expanding our reach. We are excited to soon announce the launch of a new product that has garnered significant interest in the market. Stay tuned and get ready for what promises to be a groundbreaking addition to our portfolio. Our commitment to innovation continues to drive us forward, and we are excited about what the future holds.  
2024-06-27
Hear from our Global Partners who Completed Clinical Training with PICOHI at HIRONIC! At HIRONIC, we are dedicated to providing valuable and meaningful experiences for our clients. Recently, we held a clinical training session for our revolutionary PICO laser technology, PICOHI. Our global partners shared their positive experiences and feedback from this training.As a leading manufacturer of aesthetic medical devices, we strive to ensure our clients receive the best training and support. Stay tuned for more updates and success stories!  
2024-06-27
HIRONIC is proud to announce its inclusion in South Korea's prestigious "2024 Global Leading Enterprises 1000+ Project." Our selection reflects our exceptional export performance in 2023, meeting stringent criteria that showcase our success and impact in the global market.Being among the top 200 companies in the "Global Leading Enterprises+" category is a testament to our unwavering commitment to excellence and innovation. HIRONIC's dedication to producing high-quality aesthetic medical devices has driven our international success, ensuring we remain at the forefront of the industry. Our products are designed with cutting-edge technology, providing superior solutions for medical and aesthetic needs worldwide.This recognition grants Hironic priority access to various export support initiatives from the Ministry of SMEs and Startups, as well as the Korea SMEs and Startups Agency and other related organizations. We look forward to leveraging these opportunities to expand our global reach and continue delivering outstanding products and services to our clients across the globe.  
2024-06-27
The 14th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!   
2024-06-07
On May 12th, the 46th Korean Association for Laser, Dermatology and Trichology Conference took place in Seoul, South Korea. At the conference HIRONIC showcased its products, the 'V-RO ADVANCE' (export name - New Doublo™ 2.0) and 'PICOHI™,' to a wide audience. We are grateful to everyone who expressed interest and visited the HIRONIC booth. The conference featured a series of lectures on various aspects of medical aesthetics and laser technologies, providing attendees with invaluable insights. Among other presentations, our esteemed key doctor, Dr. Kim Ki-tae from Busan Taesung Plastic Surgery, delivered a lecture titled "Solving Complications After Contour Surgery with a Single Device." He shared his experiences and know-how of working with the 'V-RO ADVANCE' (export name - New Doublo™ 2.0) in his practice.  We thank everyone for their continued interest and support. We will continue to innovate and improve our products and services to provide a better experience to all of our esteemed partners and customers.​  
2024-06-05